openPR Logo
Press release

Intratumoral Cancer Therapies Market: Unprecedented Growth, Key Players, and Emerging Trends - A Comprehensive Analysis (2024-2029)

01-22-2025 07:03 AM CET | Health & Medicine

Press release from: The Business Research Company

Intratumoral Cancer Therapies Market Share

Intratumoral Cancer Therapies Market Share

Emerging Growth and Impelling Factors in the Intratumoral Cancer Therapies Market

What Is The Projected Market Size Of The Global Intratumoral Cancer Therapies Market And Its Growth Rate?
- The market size has seen a swift growth from $140 billion in 2024, reaching $158.38 billion in 2025, ramping up at a CAGR of 13.1%.
- The growth can be attributed to advancements in cancer research, an increase in cancer incidence, demand for precision medicine, and an escalation in research initiatives.
- Rapid growth is projected in the next few years, rising to $248.42 billion in 2029 at a CAGR of 11.9%.
- This forecasted growth stems from advancements in immunotherapy, increased adoption of precision medicine, the expansion of clinical trials, a rising focus on rare cancers, and regulatory support and approvals.

What Is Driving The Growth In The Intratumoral Cancer Therapies Market?
The surge in cancer incidence worldwide propels the growth of the intratumoral cancer therapies market. Cancer, characterized by uncontrolled growth and spread of abnormal cells, increases the demand for therapies that can diagnose and treat cancer while mitigating off-target toxicities, dose-limiting toxicities, and adverse effects due to immune stimulation. The number of cancer cases, as reported by the American Cancer Society, increased to 1,958,310 in 2023, reflecting a growth of 3.16% from 1,898,160 in 2021. This escalating incidence drives the intratumoral cancer therapies market's growth.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9979&type=smp

Who Are the Key Players Driving Intratumoral Cancer Therapies Market Growth?
- Amgen Inc.
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Novartis AG
- Johnson & Johnson
- Eli Lilly and Company
- F. Hoffmann-la Roche
- Takeda Pharmaceutical Company Ltd.
- GSK plc
- Ziopharm Oncology Inc.
- Celldex Therapeutics Inc.
- Astellas Pharma Inc.
- Sirnaomics
- Checkmate Pharmaceuticals Inc.
- Immunovative Therapies Ltd.
- Idera Pharmaceuticals Inc.
- Daiichi Sankyo
- Philogen S.p.A.
- Apexigen Inc.
- Merck Group
- OncoSec Medical Incorporated
- DNAtrix
- Istari Oncology Inc.
- Nanobiotix
- Exicure Inc.
- Karyopharm Therapeutics Inc.
- Dechra Pharmaceuticals PLC
- Torigen Pharmaceuticals Inc.
- Elekta
- Virbac
- Norbrook Laboratories
- Regeneus Ltd.
- QBiotics Group
- VetDC

What Are The Key Trends In The Intratumoral Cancer Therapies Market?
Key trends spurring the forecasted growth include:
- Exploration of intratumoral immunomodulators
- Integration of image-guided therapies
- Application of hyperthermia in intratumoral treatments
- Clinical trials for combination therapies
- Regulatory support for intratumoral therapies

What Are The Segments Of The Global Intratumoral Cancer Therapies Market?
- By Technology: Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Cell Therapies, Immune System Modulator, Adoptive Cell Transfer, Cytokines.
- By Application: Lung Cancer, Breast Cancer, Melanoma, Prostate Cancer, Head And Neck Cancer, Other Applications.
- By End-Users: Hospitals, Cancer Research Centers, Clinics.

Which Region Leads The Intratumoral Cancer Therapies Market?
North America was the largest region in the intratumoral cancer therapies market in 2024. The regions covered in the market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report

What Is Covered In The Intratumoral Cancer Therapies Market Global Market Report?
Market Size Analysis: Analyze the Intratumoral Cancer Therapies Market size by key regions, countries, product types, and applications.

Market Segmentation Analysis: Identify various subsegments within the Intratumoral Cancer Therapies Market for effective categorization.

Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.

Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

Market Contribution: Evaluate contributions of different segments to the overall Intratumoral Cancer Therapies Market growth.

Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

Industry Challenges: Analyze challenges and risks affecting the Intratumoral Cancer Therapies Market.

Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/Customise?id=9979&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intratumoral Cancer Therapies Market: Unprecedented Growth, Key Players, and Emerging Trends - A Comprehensive Analysis (2024-2029) here

News-ID: 3826553 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For